Iron supplementation in ACE inhibition as a treatment for cough: is it really inoffensive?
Lev
I
I
Rian
A J
AJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000818:Animals; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000209:etiology*; D003371:Cough / Q000139:chemically induced / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000201:enzymology; D006801:Humans; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects*; D051379:Mice; D018345:Mice, Knockout; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D051381:Rats
D000806:Angiotensin-Converting Enzyme Inhibitors; D007501:Iron; D019001:Nitric Oxide Synthase